ArticleCureus2025
A Retrospective Study on the Incidence of Kaposi Sarcoma in the United States From 1999 to 2020 Using the Centers for Disease Control and Prevention Wide-Ranging Online Data for Epidemiological Research (CDC WONDER) Database.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Article
- Kaposi Sarcoma: Retrospective Clinical Analysis with a Focus on Age and HIV Serostatus.Viruses · 2026Article
- Disseminated Kaposi Sarcoma With Ocular Involvement: An Unusual Multisystem Case Presentation.Cureus · 2025Article
- Oral Soft Tissue and Jawbone Sarcomas: A Retrospective Clinicopathologic Analysis of 128 Cases from Two Institutions and Comprehensive Literature Review.Head and neck pathology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction Studying cancer incidence is important to understand the cancer risk factors, tracking trends, planning resources and developing prevention and treatment methods. Examining the incidence of Kaposi sarcoma (KS) alongside different variables enables researchers to gain insights into the disease's underlying causes and risk factors. This understanding aids in developing more focused research and interventions. Methodology A retrospective study was conducted using the Centers for Disease Control and Prevention Wide-Ranging Online Data for Epidemiological Research (CDC WONDER) database. Data were extracted on July 31, 2024. Incidence of cancer was studied based on the following variables: age, gender, race and geographic location. Results This study describes the demographic characteristics of KS patients in the United States between 1999 and 2020 based on age, gender, and race. Based on age and gender, the crude rate per 1,00,000 was highest initially in ages 75 and above and the male gender. Based on race, the crude rate per 1,00,000 was highest in the Black or African American race. Based on the state, the incidence of KS was highest in California state, followed by New York, and based on the year, the incidence of KS was highest in 2000. Conclusions Incidence in the 35-44 years age group has shown a significant decreasing trend from 2001 to 2020. Other age groups have not shown an evident decreasing or increasing trend over the years. A decreasing trend was observed in White and Black or African American populations, and stable in Asian or Pacific Islander populations, and other races and unknown combined populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.